 |
N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide, phosphate (1:2) |
|---|---|
| Trade Name | |
| Orphan Indication | Gastrointestinal Stromal Tumors |
| USA Market Approval | USA |
| USA Designation Date | 2005-01-13 00:00:00 |
| Sponsor | Amgen, Inc.;One Amgen Center Drive;Thousand Oaks, California, 91320 |
